Clarivate PLC is a leading global provider of transformative intelligence, offering enriched data, analytics, workflow software, and expert services. The company's business model is highly resilient, generating the vast majority of its revenue through recurring subscriptions to its proprietary databases and software platforms. Clarivate operates through three primary segments: Academia & Government, Intellectual Property (IP), and Life Sciences & Healthcare.
The Academia & Government segment provides scientific and academic research solutions, notably through the Web of Science platform—which calculates the impact factor of scientific journals—and ProQuest, which offers access to multidisciplinary curated content and library management software like Alma. The Intellectual Property segment supports the entire IP lifecycle, offering patent research, trademark clearance, and IP management software through flagship products such as Derwent Innovation, CompuMark, and IPfolio. The Life Sciences & Healthcare segment equips pharmaceutical and biotech companies with intelligence for drug development, regulatory compliance, and commercialization, primarily driven by its Cortellis suite and real-world data solutions.
Geographically, Clarivate serves a diverse, global client base across the Americas, EMEA, and the Asia-Pacific region. The company maintains a strong competitive moat due to the proprietary nature of its must-have datasets and its deep integration into the daily workflows of researchers, IP professionals, and life science analysts.
